JUNE 2025: Global Alzheimer’s and Brain Health Awareness Month

NEW YORK, United States, June 11, 2025 – Health organizations around the world are recognizing June as Alzheimer’s and Brain Awareness Month, calling attention to one of the fastest-growing global health concerns amid an aging population and limited treatment options.

The observance, spearheaded by the Alzheimer’s Association and supported by health ministries and advocacy groups worldwide, aims to raise awareness about dementia-related diseases and promote brain health across all age groups. It also includes “The Longest Day” campaign on June 21, symbolizing the prolonged burden of Alzheimer’s disease on patients and caregivers.

Alzheimer’s, the most common form of dementia, currently affects more than 55 million people worldwide, with an estimated 10 million new cases diagnosed each year, according to the World Health Organization (WHO). The condition is characterized by progressive cognitive decline due to neuronal damage caused by the buildup of abnormal proteins such as amyloid-beta plaques and tau tangles.

“The trajectory of Alzheimer’s disease is steepening with increased life expectancy and lifestyle changes,” said Prof. Mike Chan, Chairman of European Wellness Biomedical Group and a leading voice in regenerative medicine. “We must move from managing symptoms to targeting root causes at the cellular level.”

Regeneration Over Replacement

Current drug-based therapies, such as cholinesterase inhibitors and NMDA antagonists, offer temporary cognitive relief but have limited effect on halting disease progression. Prof. Mike Chan said advances in regenerative therapy are offering new possibilities, using targeted brain-and-organ-specific precursor stem cells to target affected brain regions.

“These include cells for the frontal and temporal lobes, cortex, thalamus, and cerebellum—all of which are involved in cognition, memory, movement, and behavior,” he said. “The goal is not just to slow decline, but to rejuvenate tissue and restore function.”

European Wellness protocols use region-specific progenitor cells derived from fetal-stage organ models to stimulate repair and reduce inflammation. Supporting cells from the placenta are also used to modulate immune response and protect against oxidative damage.

“Longevity depends on brainspan and healthspan,” Prof. Chan added. “Both are determined by the biological age of over 400 different types of stem cells across the body’s 78 organs.”

Brain Health Under Threat

Risk factors for Alzheimer’s include age, genetics, cardiovascular disease, diabetes, and a sedentary lifestyle. Symptoms typically start with short-term memory loss and progress to disorientation, language impairment, and complete dependency.

With cases expected to triple by 2050, Alzheimer’s poses significant challenges to public health systems and families alike. The global cost of dementia is projected to exceed US$1 trillion per year.

“There is a growing need for personalized, precision-based approaches to tackle neurodegeneration,” said Prof. Chan. “Generalized treatment is no longer sufficient. We must embrace science-backed, targeted interventions that address the real pathology.”

Looking Forward

June’s observance not only raises awareness but also underscores the need for early detection, lifestyle prevention, and new therapeutic models.

“The future of Alzheimer’s care must involve regenerative science,” said Prof. Chan. “Our research shows that even damaged brain tissues retain potential for repair when treated with the right types of cells.”

To learn more about available therapies at European Wellness, visit european-wellness.eu.